33 results on '"Arsov C"'
Search Results
2. Predictive power of the ESUR scoring system for prostate cancer diagnosis verified with targeted MR-guided in-bore biopsy
3. P009 - Multivariable risk-based patient selection for targeted prostate biopsy in case of suspicious Magnetic Resonance Imaging could reduce unnecessary biopsy procedures
4. Analysis of PI-RADS 4 cases: Management recommendations for negatively biopsied patients.
5. PT095 - How to prevent patients with a false positive overall score of PI-RADS 4
6. 1134 - Association of common medication with prostate-specific antigen level in 45-year-old German men: Results of the PROBASE trial
7. 468 - Multiparametric MRI can exclude prostate cancer progression in patients under active surveillance
8. 490 - Multiparametric-MRI/ultrasound fusion prostate biopsy: Are two biopsy cores per MRI-lesion required?
9. 267 - The German risk-adapted Prostate Cancer Screening Trial (PROBASE): First results after recruitment of 30.000 men
10. 247 - A positive digital rectal examination (DRE) does not predict prostate cancer in 45 yr old men - results from the German risk-adapted PCA Screening Trial (PROBASE)
11. 761 A prospective randomized study comparing MR-guided in-bore versus MRI/ultrasound fusionguided prostate biopsy in patients with prior tumor-negative TRUS biopsy
12. 321 European multi-centre study to assess the aggressiveness of prostate adenocarcinoma in newly-diagnosed patients using a cell-cycle gene expression assay (Prolaris™) in biopsy specimens (EMPATHY-P Study)
13. 214 The use of targeted MR-guided prostate biopsy reduces the risk of Gleason upgrading on radical prostatectomy
14. 23 The German risk-adapted PCA Screening Trial (PROBASE) – first results
15. 1057 Correlation of the PI-RADS score and the Gleason grade in prostate cancer lesions after targeted in bore MR-biopsy
16. 948 Comparison of targeted in-bore MRI–guided biopsy and conventional transrectal ultrasound (TRUS) – guided biopsy in biopsy-naïve patients with elevated prostate specific antigen (PSA) level
17. Comparison of 3 T mpMRI and pelvic CT examinations for detection of lymph node metastases in patients with prostate cancer.
18. Reasons for missing clinically significant prostate cancer by targeted magnetic resonance imaging/ultrasound fusion-guided biopsy.
19. A0815 - MRI-guided active surveillance without re-biopsy in patients with ISUP 1 and 2 prostate cancer – results of radical prostatectomy and mid-term follow up of the prospective PROMM-AS study.
20. Improved diffusion-weighted imaging of the prostate: Comparison of readout-segmented and zoomed single-shot imaging.
21. A0960 - MRI-guided Active Surveillance without annual re-biopsy in patients with ISUP 1 and 2 prostate cancer – The prospective PROMM-AS Study.
22. P239 - Worry about prostate cancer and risk perception among middle-aged men: Results from the PROBASE trial.
23. Arterial spin labelling as a gadolinium-free alternative in the detection of prostate cancer.
24. A0899 - Digital Rectal Examination (DRE) is not useful as a solitary screening tool for prostate cancer in young men – Results from the PROBASE trial.
25. Influence of arterial input function (AIF) on quantitative prostate dynamic contrast-enhanced (DCE) MRI and zonal prostate anatomy.
26. Magnetic resonance imaging of the prostate at 1.5 versus 3.0T: A prospective comparison study of image quality.
27. Impact of dynamic contrast-enhanced MRI in 1.5 T versus 3 T MRI for clinically significant prostate cancer detection.
28. A0558 - Complications of primary open or robotic RetroPeritoneal Lymph Node Dissection (RPLND) in stage II A/B patients with seminoma – results from the prospective phase II PRIMETEST trial.
29. V12 EXTRAPERITONEAL LAPARO-ENDOSCOPIC SINGLE SITE RADICAL PROSTATECTOMY (LESS)
30. Comparison and prediction of artefact severity due to total hip replacement in 1.5 T versus 3 T MRI of the prostate.
31. PSMA PET/CT vs. CT alone in newly diagnosed biochemical recurrence of prostate cancer after radical prostatectomy: Comparison of detection rates and therapeutic implications.
32. Advanced diffusion weighted imaging of the prostate: Comparison of readout-segmented multi-shot, parallel-transmit and single-shot echo-planar imaging.
33. 89 The association between family history and prostate-specific antigen from a large group of 45-year old men embarking on prostate cancer screening: Results from the PROBASE trial.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.